DME Resupply Fraud: The Shipment Is Not the Request

DME resupply fraud turns recurring supplies into false Medicare claims when a supplier knowingly bills for refills that patients did not request, receive or need. Taxpayers pay for supplies that never become patient care. The original prescription starts the relationship. Each later shipment has its own requirements, and the employee taking refill calls or releasing orders can see whether anyone actually asked for it. A box leaving the warehouse proves that something shipped. The patient’s response shows whether the refill was requested before it left.

When Billing Continued After Use Stopped

Lincare’s February 2024 civil settlement required it to pay $25.5 million over non-invasive ventilator billing and coinsurance-waiver claims. Lincare admitted that it sometimes kept seeking monthly payments from federal health care programs when it knew patients were not using the devices.

It also admitted that clinical staff missed home visits required by its own policy, that usage documentation was missing in many instances, and that available remote-monitoring systems went unused. Some of the machines could report usage. Lincare kept billing without using that information to confirm it. The government joined a case brought by a whistleblower.

Rotech’s 2018 settlement over portable oxygen contents addressed another recurring claim stream. Rotech agreed to pay $9.68 million and admitted knowingly billing for contents patients did not use or require, regardless of whether the contents were delivered. A former billing-department employee brought the case. The employee’s view of the recurring charges reached a practice that the delivery and patient-use records could contradict.

What Must Happen Before a Durable Medical Equipment Refill Ships?

For supplies covered by the ordinary refill rule, the supplier must contact the patient or their representative and document an affirmative response before dispensing the refill. Giving DME refill consent once does not cover every future shipment. The Centers for Medicare & Medicaid Services’ refill guidance expressly prohibits automatic shipments on a predetermined schedule, even when the patient authorized them.

For DME supplies, contact and confirmation must occur within 30 calendar days before the expected end of the current supply. Delivery must be no sooner than 10 calendar days before that expected end. The patient’s expected supply end sets the clock. The warehouse’s preferred shipping date does not.

The request identifies the patient or authorized representative, the items requested, the affirmative response showing a need for the refill, and the request date. The original order, the refill response and the delivery record answer different questions. Together they connect what was prescribed, what the patient needs now and what the supplier sent.

Permission to make a call is a separate question. The Medicare telephone-contact FAQ distinguishes a physician referral made with the patient’s knowledge from a supplier calling solely because it received an order. The first contact about that prescribed item cannot become a sales call for additional covered items. An order on file supplies neither an unlimited sales invitation nor a standing refill request.

Automatic Text Refill Responses and Medicare DME Documentation

For an automatic text refill response, Medicare DME documentation must capture the patient’s actual affirmative response and the other required request details. Medicare allows automated texts and email. The communication method can be automated. The response still has to come from the patient or their representative.

A sent message records outreach. A reply requesting the identified supplies records something more. Medicare’s standard documentation article requires the refill request to occur and be documented before shipment. That sequence is the useful comparison for a call-center employee: the outgoing message, the reply and the release of the order.

What Changed on January 1, 2024?

On January 1, 2024, Medicare removed the refill documentation duties to assess remaining consumable quantities and describe why nonconsumable supplies had stopped functioning. It retained medical necessity and required a documented affirmative response. If a DME supplier stopped counting remaining supplies in January 2024, the question for its later claims is whether it still obtained and documented the patient’s need for each refill.

The final rule changing refill requirements also replaced the earlier contact window. Previously, contact could occur no sooner than 14 calendar days before delivery or shipping. The current window runs back from expected supply exhaustion. Both the length of the window and the event that starts the calculation changed.

What Documentation Must Be Created to Ensure That the Claim Would Pass an Audit?

For a shipped refill, an audit compares the request and affirmative response with the shipment date, medical-necessity records and proof of delivery. The documentation article’s revision history shows why the claim date matters: older claims required remaining quantities for consumables such as catheters and ostomy supplies, and the functional condition of replacement items such as PAP supplies.

Those older requirements matter when examining older claims. The current rule still asks whether the patient needs the refill. Removing the inventory count did not remove the patient from the transaction.

CPAP Resupply Request Documented After Shipment

A CPAP resupply request documented after shipment fails the requirement for a request recorded before the goods leave. A later statement from the supplier or patient cannot stand in for it.

This matters because replacement accessories can remain a business long after payment for the machine ends. After Medicare pays for 13 months of continuous use of a PAP machine, it treats the patient’s original need for that machine as established when reviewing replacement-accessory claims. Masks, tubing, filters and humidifier chambers still have their own supply requirements.

Medicare’s Program Integrity Manual tells reviewers to examine whether the machine and refill accessory are still needed. The treating practitioner must still document that the machine remains medically necessary.

Continued use also matters. Medicare’s general documentation policy requires suppliers to stop billing for ongoing supplies when the patient no longer uses them. A compliant refill-request record can itself support continued use of the base device. The PAP coverage policy also bars quantities exceeding expected use and requires attention to changed or unusual use patterns. A request, a usage record and a shipment record each tell part of the story.

Urological Refills and Continuous Glucose Monitor Supplies

For a permanent urological condition, continued medical need does not replace a refill request. Medicare’s urological supplies policy generally assumes ongoing need once initial need for permanent urinary incontinence or retention is established and the patient continues to meet the coverage conditions.

The urological coverage policy still requires the patient’s affirmative response before each refill. A permanent condition does not tell the supplier that this patient needs this shipment now.

Continuous glucose monitor supply allowances have a different rule. The ordinary refill requirements do not apply to A4238 or A4239, but the glucose monitor policy article requires suppliers to monitor usage and provide enough supplies for the period billed. Suppliers may not dispense more than a 90-day supply, and the patient must still meet the continued-coverage requirements.

For a billing employee, that distinction matters: the continuous glucose monitor exception does not carry over to catheter refills or CPAP masks.

The Records Refill Staff Hold

Refill staff can connect what a patient said with what fulfillment released and billing charged. Call recordings, text responses and request timestamps show the contact. Shipment records and proof of delivery show the goods’ movement. Claims show what Medicare was asked to pay. The comparison becomes especially useful when a request appears only after shipment, or the patient declined supplies and an approval nevertheless appears in the system.

An earlier whistleblower complaint against Lincare and Med4Home describes that kind of contradiction in a mail-order medication business. A programmer alleged that the system blocked shipments when a physician refused a prescription, but database changes turned those refusals into approvals:

The whistleblower also alleged that the business increased the number of authorized refills and split shipments instead of consolidating them. The apparent approval lived inside the software. The supporting physician record told another story.

That is why the history of a record matters alongside its final appearance. We examine who entered or changed an approval, when the goods left and what was billed. Instructions to staff and messages about known problems can connect the recurring claims to decisions inside the business.

Why Resupply Became the Durable Medical Equipment Business

The equipment starts a patient relationship that can outlast the equipment payments. Masks and other replacement supplies keep generating claims while the patient continues treatment. For a healthcare supplier, keeping that relationship means more than selling a machine. It means handling later requests, arranging deliveries and billing for supplies over time.

The service that obtains those requests can itself become a financial inducement. In a complaint concerning Respironics’ medSage program, a whistleblower alleged that suppliers received free call-center services for patients using Respironics masks while paying for the same service for patients using competing masks. The alleged incentive reached the choice of mask through the cost of running the resupply operation.

The broader enforcement picture reaches Medicaid too. The Department of Health and Human Services’ Office of Inspector General’s Medicaid Fraud Control Units Fiscal Year 2023 Annual Report, published in 2024, identified medical-device manufacturers and durable medical equipment suppliers as the provider types associated with the most civil settlements and judgments.

For an insider, the useful starting point remains the particular shipment and claim. You may know which responses were real, which approvals were changed and who kept the orders moving. A qui tam case under the False Claims Act can pay 15% to 30% of what the government recovers.

When You Know How the Refills Were Approved

If you work in refill calls, fulfillment, billing or clinical operations and can connect patient responses to shipments and claims, speak with our whistleblower experts about the resupply operation. We work with you to build your strongest resupply fraud whistleblower case around the recurring charges and the people who knew how they were generated. We stay beside you through the case and bring in durable medical equipment fraud whistleblower lawyers who understand supply billing.